Workflow
发行股份及可转换公司债券购买资产并募集配套资金
icon
Search documents
北京阳光诺和药物研究股份有限公司关于2025年第四次临时股东会的延期公告
Group 1 - The fourth extraordinary general meeting of shareholders originally scheduled for October 23, 2025, has been postponed to October 30, 2025 [2][3] - The postponement is due to the ongoing approval process by the state-owned enterprise involved in the transaction, ensuring the smooth execution of the deal and protecting shareholders' rights [2] - Other arrangements, including the equity registration date and agenda items for the meeting, remain unchanged [2][4] Group 2 - The postponed meeting will take place at 14:30 on October 30, 2025, with online voting available on the same day [3] - The network voting period will be from 9:15 to 15:00 on the day of the meeting, with specific time slots for trading system voting [3] - Shareholders or their agents are responsible for their own travel and accommodation expenses when attending the meeting [5]